We first tested if known relevant nuclear envelope components in ovarian cancer were deregulated according to cancer nuclear morphological diversification, including LMNA, Lamin B1 and B2, Emerin, nucleoporins NUP88 and NUP1532. The gene discussed is LMNA; the disease is ovarian carcinoma.